Biotika A.S. Logo

Biotika A.S.

Biotech firm making penicillin & polymyxin B APIs for human/vet use, plus contract manufacturing.

BSL | BSSE

Overview

Corporate Details

ISIN(s):
SK1120004009
LEI:
097900BGMP0000060091
Country:
Slovakia
Address:
566, 976 13 Slovenská Ľupča
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Biotika A.S. is a Slovak biotechnology company and manufacturer of Active Pharmaceutical Ingredients (APIs) with a tradition spanning over 70 years. The company specializes in the biotechnological production of APIs, with its main products being penicillin and polymyxin B sulfate for both human and veterinary applications. In addition to its core production, Biotika offers contract manufacturing services, including the transfer and scaling of biotechnological products from laboratory to commercial production. The company is also engaged in research and development within the field of biotechnology.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-06-24 11:04
Post-Annual General Meeting Information
Uznesenia z RVZ Biotika a.s. z 18.6.2025
Slovak 85.4 KB
2025-05-16 08:20
Pre-Annual General Meeting Information
Oznámenie o konaní VZ dňa 18.6.2025
Slovak 126.3 KB
2025-04-30 11:55
Report Publication Announcement
Inzercia v HN Ročná finančná správa 2024
Slovak 631.5 KB
2025-01-30 15:19
Post-Annual General Meeting Information
Uznesenia z MVZ Biotika a.s. z 29.1.2025
Slovak 178.9 KB
2024-12-20 13:16
Pre-Annual General Meeting Information
Oznámenie o konaní MVZ dňa 29.1.2025
Slovak 51.0 KB
2024-12-19 08:50
Declaration of Voting Results & Voting Rights Announcements
Zmena podielu na hlasovacích právach emitenta
Slovak 1.2 MB
2024-04-12 13:57
Post-Annual General Meeting Information
Uznesenia z RVZ Biotika a.s. z 11.4.2024
Slovak 135.0 KB
2024-03-11 15:24
Pre-Annual General Meeting Information
Oznámenie o konaní VZ dňa 11.4.2024
Slovak 153.0 KB
2024-01-31 12:08
Declaration of Voting Results & Voting Rights Announcements
Biotika zmeny v podieloch na hlasovacích právach
Slovak 157.3 KB
2024-01-18 11:48
Interim Report
Polročná finančná správa 2023 doplnenie
Slovak 303.6 KB
2023-08-23 13:49
Declaration of Voting Results & Voting Rights Announcements
Oznámenie o zmene hlasovacích práv
Slovak 60.2 KB
2023-08-22 14:56
Major Shareholding Notification
Oznámenie o nadobudnutí hlasovacích práv - Vinohrady Investments, a.s.
Slovak 525.0 KB
2023-08-22 14:55
Declaration of Voting Results & Voting Rights Announcements
Oznámenie o prevode hlasovacích práv - BIO S.L., a.s.
Slovak 511.8 KB
2023-03-31 13:54
Post-Annual General Meeting Information
Uznesenia z RVZ Biotika a.s. z 30.3.2023
Slovak 596.2 KB
2023-02-27 10:55
Pre-Annual General Meeting Information
Oznámenie o konaní VZ dňa 30.3.2023
Slovak 151.9 KB

Automate Your Workflow. Get a real-time feed of all Biotika A.S. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Biotika A.S.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Biotika A.S. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
KANABO GROUP PLC Logo
Develops cannabis formulas and vaporization devices for the medical and consumer wellness markets.
United Kingdom KNB
Kancera Logo
Develops small molecule drugs targeting the fractalkine axis for cancer and inflammatory diseases.
Sweden KAN
KANGSTEM BIOTECH CO., LTD. Logo
Develops stem cell therapies for rare diseases; offers culture media, cell platforms, and CDMO services.
South Korea 217730
Karo Pharma AB Logo
Develops and sells everyday healthcare products, focusing on OTC and skin health in Europe.
Sweden KARO
KBIO COMPANY Inc. Logo
Using a plant-based platform to rapidly develop biologics for public health.
South Korea 038530
Keeps Biopharma Inc. Logo
Develops cancer therapies and obesity drugs; manufactures industrial and cleanroom products.
South Korea 256940
Kidswell Bio Corporation Logo
Biopharma R&D of biosimilars, biologics, and cell therapies, with a pediatric focus.
Japan 4584
Kinarus Therapeutics Holding AG Logo
A specialty pharma firm developing and selling medicines for rare and specialty diseases.
Switzerland KNRS
KISSEI PHARMACEUTICAL CO.,LTD. Logo
Develops innovative drugs for urology, renal diseases, and rare or intractable diseases.
Japan 4547
Klaria Pharma Holding AB Logo
Develops oral films for non-invasive drug delivery as an alternative to injections and sprays.
Sweden KLAR

Talk to a Data Expert

Have a question? We'll get back to you promptly.